Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bio-Rad Laboratories, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BIO
New York
3840
www.bio-rad.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bio-Rad Laboratories, Inc.
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity
- Dec 12th, 2025 8:18 am
Bio-Rad, Poly Medicure, and Sekisui Medical Power Rapid Expansion in the Venous Blood Collection Market Through 2032
- Dec 12th, 2025 8:15 am
A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)
- Nov 30th, 2025 5:03 am
Autoimmune Disease Diagnostics Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
- Nov 24th, 2025 9:05 am
HbA1c Testing Market Research Report 2025-2033, Profiles of Key Players - Danaher, F. Hoffmann-La Roche, Siemens, Abbott, Bio-Rad Laboratories, ARKRAY, Trinity Biotech, EKF Diagnostics
- Nov 3rd, 2025 2:18 am
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO?
- Nov 2nd, 2025 9:19 pm
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday
- Oct 30th, 2025 3:17 pm
Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls
- Oct 30th, 2025 7:04 am
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
- Oct 30th, 2025 4:17 am
Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates
- Oct 29th, 2025 3:55 pm
Bio-Rad: Q3 Earnings Snapshot
- Oct 29th, 2025 3:23 pm
Bio-Rad Reports Third-Quarter 2025 Financial Results
- Oct 29th, 2025 2:15 pm
Bio-Rad (BIO) Surged as the Earnings Exceeded Expectations
- Oct 24th, 2025 11:30 am
What Makes Bio-Rad Laboratories (BIO) an Investment Bet?
- Oct 23rd, 2025 9:44 am
Envista (NVST) Earnings Expected to Grow: Should You Buy?
- Oct 23rd, 2025 8:00 am
A Look at Bio-Rad Laboratories’s Valuation Following Expanded Biodesix Partnership in Cancer Diagnostics
- Oct 23rd, 2025 4:12 am
Bio-Rad Laboratories (BIO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Oct 22nd, 2025 8:00 am
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
- Oct 22nd, 2025 4:17 am
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
- Oct 16th, 2025 3:30 pm
Aurora Cannabis (ACB) Soars 6.2%: Is Further Upside Left in the Stock?
- Oct 8th, 2025 4:12 am
Scroll